{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:49:37Z","timestamp":1760060977185,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institute of Health\u2013National Institute on Drug Abuse (NIH-NIDA)","award":["DA028154-02"],"award-info":[{"award-number":["DA028154-02"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jsat.2014.10.012","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T08:30:37Z","timestamp":1415176237000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Substance Use and Response to Psychiatric Treatment in Methadone-Treated Outpatients with Comorbid Psychiatric Disorder"],"prefix":"10.1016","volume":"51","author":[{"given":"Michael","family":"Kidorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van L.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Peirce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj","family":"Gandotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Ghazarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Brooner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2014.10.012_bb0005","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/add.12269","article-title":"Managing psychiatric comorbidity within versus outside of methadone treatment settings. A randomized and controlled evaluation","volume":"108","author":"Brooner","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2014.10.012_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2014.10.012_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0376-8716(00)00148-4","article-title":"The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients","volume":"61","author":"Cacciola","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.10.012_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugalcdep.2003.11.015","article-title":"The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: A controlled clinical trial","volume":"74","author":"Carpenter","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.10.012_bb0030","series-title":"DHHS Publication No. (SMA) 05-3922)","article-title":"Substance abuse treatment for persons with co-occurring disorders. TIP series 42 No","author":"Center for Substance Abuse Treatment","year":"2005"},{"key":"10.1016\/j.jsat.2014.10.012_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00005053-199705000-00002","article-title":"Sedative use disorders in opiate-dependent patients: Association with psychiatric and other substance use disorders","volume":"185","author":"Chutuape","year":"1997","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2014.10.012_bb0035","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1176\/appi.ajp.160.5.890","article-title":"The role of psychiatric disorders in predicting drug dependence treatment outcomes","volume":"160","author":"Compton","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2014.10.012_bb0045","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1360-0443.2007.01876.x","article-title":"Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence","volume":"102","author":"Darke","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2014.10.012_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0376-8716(93)90047-T","article-title":"Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients","volume":"34","author":"Darke","year":"1993","journal-title":"Drug and Alcohol Dependence"},{"year":"1983","series-title":"SCL-90-R. Administration, scoring, and procedures manual II","author":"Derogatis","key":"10.1016\/j.jsat.2014.10.012_bb0055"},{"key":"10.1016\/j.jsat.2014.10.012_bb0060","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0","article-title":"Confirmation of the dimensional structure of the SCL-90: A study in construct validation","volume":"33","author":"Derogatis","year":"1977","journal-title":"Journal of Clinical Psychology"},{"key":"10.1016\/j.jsat.2014.10.012_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2004.11.012","article-title":"Prevalence and correlates of cocaine physical dependence subtypes using the DSM-IV in outpatients receiving opioid agonist medication","volume":"79","author":"Disney","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.10.012_bb0065","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.socscimed.2004.06.052","article-title":"Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: A qualitative systematic review of randomized controlled trials","volume":"60","author":"Donald","year":"2005","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.jsat.2014.10.012_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2008.11.006","article-title":"Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency","volume":"101","author":"Epstein","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"year":"1995","series-title":"Structured Clinical Interview for DSM-IV Axis Disorders\u2013Patient Edition (SCID-I\/P, Version 2.0)","author":"First","key":"10.1016\/j.jsat.2014.10.012_bb0075"},{"key":"10.1016\/j.jsat.2014.10.012_bb0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2014.10.012_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2013.06.005","article-title":"Reinforcing integrated psychiatric service attendance in an opioid-agonist program: A randomized and controlled trial","volume":"133","author":"Kidorf","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.10.012_bb0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1037\/0022-006X.66.1.168","article-title":"Predictive validity of cocaine, sedative, and alcohol dependence diagnoses","volume":"66","author":"Kidorf","year":"1998","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.jsat.2014.10.012_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.drugalcdep.2003.11.014","article-title":"Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program","volume":"74","author":"Kidorf","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.10.012_bb0100","series-title":"The treatment of opioid dependence","first-page":"119","article-title":"Counseling and psychosocial services","author":"Kidorf","year":"2006"},{"key":"10.1016\/j.jsat.2014.10.012_bb0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1360-0443.2003.00669.x","article-title":"Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholic s or non-drug-using controls","volume":"99","author":"Kirby","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2014.10.012_bb0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpsyc.1983.04390010059007","article-title":"Imipramine as treatment for depression in addicts","volume":"40","author":"Kleber","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2014.10.012_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","article-title":"Benzodiazepines, methadone, and burprenorphine: Interaction and clinical management","volume":"19","author":"Lintzeris","year":"2010","journal-title":"American Journal on the Addictions"},{"key":"10.1016\/j.jsat.2014.10.012_bb0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jsat.2006.05.003","article-title":"Addiction treatment services and co-occurring disorders","volume":"31","author":"McGovern","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2014.10.012_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2014.10.012_bb0135","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.291.15.1887","article-title":"Treatment of depression in patients with alcohol or other drug dependence","volume":"291","author":"Nunes","year":"2004","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2014.10.012_bb0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.55.2.153","article-title":"Imipramine treatment of opiate-dependent patients with depressive disorders","volume":"55","author":"Nunes","year":"1998","journal-title":"Archives of General Psychiatry"},{"year":"2010","series-title":"Substance dependence and co-occurring psychiatric disorders: Best practices for diagnosis and clinical treatment","key":"10.1016\/j.jsat.2014.10.012_bb0145"},{"year":"2011","series-title":"Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy","author":"Pedrelli","key":"10.1016\/j.jsat.2014.10.012_bb0150"},{"key":"10.1016\/j.jsat.2014.10.012_bb0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archpsyc.63.2.201","article-title":"Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug abuse Treatment Clinical Trials Network study","volume":"63","author":"Peirce","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2014.10.012_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0376-8716(98)00032-5","article-title":"Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts","volume":"50","author":"Petrakis","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.10.012_bb0165","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1360-0443.1996.918119711.x","article-title":"Pre-treatment characteristics, program philosophy, and level of ancillary services as predictors of methadone maintenance treatment outcome","volume":"91","author":"Saxon","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2014.10.012_bb0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/archpsyc.61.2.152","article-title":"Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users","volume":"61","author":"Stein","year":"2004","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2014.10.012_bb0175","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/00002508-200207001-00003","article-title":"Assessment and treatment of comorbid psychiatric disorders","volume":"18","author":"Strain","year":"2002","journal-title":"Clinical Journal of Pain"},{"key":"10.1016\/j.jsat.2014.10.012_bb0180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00213-006-0632-8","article-title":"Profile of executive deficits in cocaine and heroin polysubstance users: Common and differential effects on separate executive components","volume":"190","author":"Verdejo-Garcia","year":"2007","journal-title":"Psychopharmacology"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214002232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214002232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:42:48Z","timestamp":1760038968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547214002232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":35,"alternative-id":["S0740547214002232"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2014.10.012","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance Use and Response to Psychiatric Treatment in Methadone-Treated Outpatients with Comorbid Psychiatric Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2014.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}